Leanne Kelly

Leanne Kelly is an accomplished financial executive with extensive experience in the biopharmaceutical and pharmaceutical industries. Currently serving as Chief Financial Officer at GRI Bio, Inc. and a Board Member at Windtree Therapeutics, Inc., Leanne has held significant leadership roles, including Chief Financial Officer at Vallon Pharmaceuticals and Controller at Optinose. Demonstrating expertise in financial reporting, compliance, and strategic financial management, Leanne has successfully transitioned companies to GAAP compliance and overseen substantial funding initiatives. A graduate of Lehigh University with degrees in Accounting and Finance and Business and Economics, Leanne combines a strong educational foundation with a proven track record in financial leadership.